Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
一项针对儿童的开放标签 I/II 期临床试验，研究 SARS-CoV-2 受体结合域-破伤风类毒素结合疫苗 (FINLAY-FR-2) 与受体结合域-蛋白疫苗 (FINLAY-FR-1A) 联合用药的疗效。
期刊:International Journal of Infectious Diseases
影响因子:4.3
doi:10.1016/j.ijid.2022.11.016
Puga-Gómez, Rinaldo; Ricardo-Delgado, Yariset; Rojas-Iriarte, Chaumey; Céspedes-Henriquez, Leyanis; Piedra-Bello, Misleidys; Vega-Mendoza, Dania; Pérez, Noelvia Pestana; Paredes-Moreno, Beatriz; Rodríguez-González, Meiby; Valenzuela-Silva, Carmen; Sánchez-Ramírez, Belinda; Rodríguez-Noda, Laura; Pérez-Nicado, Rocmira; González-Mugica, Raul; Hernández-García, Tays; Fundora-Barrios, Talía; Echevarría, Martha Dubet; Enriquez-Puertas, Juliet María; Infante-Hernández, Yenicet; Palenzuela-Díaz, Ariel; Gato-Orozco, Evelyn; Chappi-Estévez, Yanet; Francisco-Pérez, Julio Cesar; Suarez-Martinez, Miladi; Castillo-Quintana, Ismavy C; Fernandez-Castillo, Sonsire; Climent-Ruiz, Yanet; Santana-Mederos, Darielys; García-Vega, Yanelda; Toledo-Romani, María Eugenia; Doroud, Delaram; Biglari, Alireza; Valdés-Balbín, Yury; García-Rivera, Dagmar; Vérez-Bencomo, Vicente
